心房颤动患者生活质量评估及治疗策略影响相关进展
Advances in the Impact of the Assessment of Quality of Life and Treatment Strategies for Patients with Atrial Fibrillation
DOI: 10.12677/acm.2025.1582374, PDF,   
作者: 刘 盼：吉首大学医学院，湖南 吉首；彭林林*：吉首大学第一附属医院心内科(湘西土家族苗族自治州人民医院)，湖南 吉首
关键词: 心房颤动；生活质量；影响；Atrial Fibrillation； Quality of Life； Impact
摘要: 心房颤动(房颤)是最常见的持续性心律失常，显著增加死亡、脑卒中等相关疾病风险，严重影响生活质量。生活质量又称为生命质量或生存质量，是一个多维度、抽象的概念，目前，常用于房颤患者的生活质量量表分为通用量表健康调查简表36、疾病特异性量表房颤生活质量量表18等。房颤治疗目标主要以卒中预防、症状控制为主，临床实践中，评估房颤患者治疗策略对生活质量的影响，有利于确立个体化治疗。本文现就对房颤患者生活质量评估及治疗策略的影响展开综述。
Abstract: Atrial fibrillation (AF) is the most common persistent arrhythmia. Atrial fibrillation significantly increases the risk of death, stroke and other related diseases, and seriously affects the quality of life. Quality of life, also known as quality of existence or quality of survival, is a multi-dimensional and abstract concept. At present, the quality of life scales commonly used in patients with atrial fibrillation are divided into the General Health Questionnaire 36 (GHQ-36) and the Atrial Fibrillation Quality of Life Scale 18 (AF-QoL-18). The main goals of atrial fibrillation treatment are stroke prevention and symptom control. In clinical practice, evaluating the impact of treatment strategies on the quality of life of patients with atrial fibrillation is conducive to the establishment of individualized treatment. This article reviews the impact of the assessment of quality of life and treatment strategies for patients with atrial fibrillation.
文章引用：刘盼, 彭林林. 心房颤动患者生活质量评估及治疗策略影响相关进展[J]. 临床医学进展, 2025, 15(8): 1358-1364. https://doi.org/10.12677/acm.2025.1582374

参考文献

[1] 中华医学会心电生理和起搏分会, 中国医师协会心律学专业委员会, 中国房颤中心联盟心房颤动防治专家工作委员会. 心房颤动: 目前的认识和治疗建议(2021) [J]. 中华心律失常学杂志, 2022, 26(1): 15-88.
[2] Haraldstad, K., Wahl, A., Andenæs, R., Andersen, J.R., Andersen, M.H., Beisland, E., et al. (2019) A Systematic Review of Quality of Life Research in Medicine and Health Sciences. Quality of Life Research, 28, 2641-2650. [Google Scholar] [CrossRef] [PubMed]
[3] 李雁楠, 李镒冲, 张梅, 等, 健康相关生命质量的研究进展[J]. 中华流行病学杂志, 2016, 37(9): 1311-1317.
[4] Katz, S. (1963) Studies of Illness in the Aged: A Standardized Measure of Biological and Psychosocial Function. JAMA, 185, 914-919. [Google Scholar] [CrossRef] [PubMed]
[5] Hörnquist, J.O. (1982) The Concept of Quality of Life. Scandinavian Journal of Social Medicine, 10, 57-61. [Google Scholar] [CrossRef] [PubMed]
[6] Levi, L. (1997) Psychosocial Environ Mental Factors and Psychosocially Mediated Effects of Physical Environ Mental Factors. Scandinavian Journal of Work, Environment & Health, 23, 47-52.
[7] 李颖怡, 王群山. 心房颤动患者的生活质量评估和最新症状分级方法[J]. 中国循环杂志, 2015, 30(7): 708-710.
[8] 杨建芳, 柳建红, 周兆欣, 等. 心房颤动患者生活质量评估方法及其影响因素研究进展[J]. 甘肃医药, 2024, 43(6): 496-499.
[9] Ware, J.E. and Sherbourne, C.D. (1992) The MOS 36-Ltem Short-Form Health Survey (SF-36): I. Conceptual Framework and Item Selection. Medical Care, 30, 473-483. [Google Scholar] [CrossRef] 
[10] Mohanty, S., Santangeli, P., Mohanty, P., Biase, L.D., Holcomb, S., Trivedi, C., et al. (2014) Catheter Ablation of Asymptomatic Longstanding Persistent Atrial Fibrillation: Impact on Quality of Life, Exercise Performance, Arrhythmia Perception, and Arrhythmia-Free Survival. Journal of Cardiovascular Electrophysiology, 25, 1057-1064. [Google Scholar] [CrossRef] [PubMed]
[11] Badia, X., Arribas, F., Ormaetxe, J.M., Peinado, R. and de los Terreros, M.S. (2007) Development of a Questionnaire to Measure Health-Related Quality of Life (HRQoL) in Patients with Atrial Fibrillation (AF-QoL). Health and Quality of Life Outcomes, 5, Article No. 37. [Google Scholar] [CrossRef] [PubMed]
[12] Spertus, J., Dorian, P., Bubien, R., Lewis, S., Godejohn, D., Reynolds, M.R., et al. (2011) Development and Validation of the Atrial Fibrillation Effect on Quality-of-Life (AFEQT) Questionnaire in Patients with Atrial Fibrillation. Circulation: Arrhythmia and Electrophysiology, 4, 15-25. [Google Scholar] [CrossRef] [PubMed]
[13] 张欢, 钟理, 陈兴华, 等. 房颤特异性生活质量量表的汉化和信效度评价[J]. 现代预防医学, 2020, 47(3): 471-473+478.
[14] Kirchhof, P., Camm, A.J., Goette, A., et al. (2020) East-AFNET 4 Trial Investigators. Early Rhythm-Control Therapy in Patients with Atrial Fibrillation. The New England Journal of Medicine, 383, 1305-1316.
[15] Groenveld, H.F., Crijns, H.J., van Den Berg, M.P., et al. (2011) Race II Investigators. The Effect of Rate Control on Quality of Life in Patients with Permanent Atrial Fibrillation: Data from the RACE II (Rate Control Efficacy in Permanent Atrial Fibrillation II) Study. American College of Cardiology, 58, 1795-803.
[16] Van Gelder, I.C., Groenveld, H.F., Crijns, H.J.G.M., Tuininga, Y.S., Tijssen, J.G.P., Alings, A.M., et al. (2010) Lenient versus Strict Rate Control in Patients with Atrial Fibrillation. New England Journal of Medicine, 362, 1363-1373. [Google Scholar] [CrossRef] [PubMed]
[17] Kirchhof, P., Camm, A.J., Goette, A., et al. (2020) EAST-AFNET 4 Trial Investigators. Early Rhythm-Control Therapy in Patients with Atrial Fibrillation. New England Journal of Medicine, 383, 1305-1316.
[18] Page, R.L., Connolly, S.J., Crijns, H.J.G.M., van Eickels, M., Gaudin, C., Torp-Pedersen, C., et al. (2011) Rhythm-and Rate-Controlling Effects of Dronedarone in Patients with Atrial Fibrillation (from the ATHENA Trial). The American Journal of Cardiology, 107, 1019-1022. [Google Scholar] [CrossRef] [PubMed]
[19] Camm, A.J., Breithardt, G., Crijns, H., Dorian, P., Kowey, P., Le Heuzey, J., et al. (2011) Real-Life Observations of Clinical Outcomes with Rhythm-and Rate-Control Therapies for Atrial Fibrillation: RECORDAF (Registry on Cardiac Rhythm Disorders Assessing the Control of Atrial Fibrillation). Journal of the American College of Cardiology, 58, 493-501. [Google Scholar] [CrossRef] [PubMed]
[20] Van Gelder, I.C., Rienstra, M., Bunting, K.V., Casado-Arroyo, R., Caso, V., Crijns, H.J.G.M., et al. (2024) 2024 ESC Guidelines for the Management of Atrial Fibrillation Developed in Collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). European Heart Journal, 45, 3314-3414. [Google Scholar] [CrossRef] [PubMed]
[21] Rush, K.L., Seaton, C.L., Burton, L., Loewen, P., O’Connor, B.P., Moroz, L., et al. (2023) Quality of Life among Patients with Atrial Fibrillation: A Theoretically-Guided Cross-Sectional Study. PLOS ONE, 18, e0291575. [Google Scholar] [CrossRef] [PubMed]
[22] Blum, S., Muff, C., Aeschbacher, S., Ammann, P., Erne, P., Moschovitis, G., et al. (2017) Prospective Assessment of Sex-Related Differences in Symptom Status and Health Perception among Patients with Atrial Fibrillation. Journal of the American Heart Association, 6, e005401. [Google Scholar] [CrossRef] [PubMed]
[23] Randolph, T.C., Simon, D.N., Thomas, L., Allen, L.A., Fonarow, G.C., Gersh, B.J., et al. (2016) Patient Factors Associated with Quality of Life in Atrial Fibrillation. American Heart Journal, 182, 135-143. [Google Scholar] [CrossRef] [PubMed]
[24] Abu, H.O., Saczynski, J.S., Mehawej, J., Tisminetzky, M., Kiefe, C.I., Goldberg, R.J., et al. (2020) Clinically Meaningful Change in Quality of Life and Associated Factors among Older Patients with Atrial Fibrillation. Journal of the American Heart Association, 9, e016651. [Google Scholar] [CrossRef] [PubMed]
[25] Kotecha, D., Bunting, K.V., Gill, S.K., Mehta, S., Stanbury, M., Jones, J.C., et al. (2020) Effect of Digoxin vs Bisoprolol for Heart Rate Control in Atrial Fibrillation on Patient-Reported Quality of Life: The RATE-AF Randomized Clinical Trial. JAMA, 324, 2497-2508. [Google Scholar] [CrossRef] [PubMed]
[26] Tønnesen, J., Ruwald, M.H., Pallisgaard, J., Rasmussen, P.V., Johannessen, A., Hansen, J., et al. (2024) Lower Recurrence Rates of Atrial Fibrillation and MACE Events after Early Compared to Late Ablation: A Danish Nationwide Register Study. Journal of the American Heart Association, 13, e032722. [Google Scholar] [CrossRef] [PubMed]
[27] Sun, Y., Zhu, J., Ma, C., Liu, S., Yang, Y. and Hu, D. (2019) Stroke Risk Status, Anticoagulation Treatment, and Quality-of-Life in Chinese Patients with Atrial Fibrillation: China Registry of Atrial Fibrillation (CRAF). Cardiovascular Therapeutics, 2019, Article ID: 7372129. [Google Scholar] [CrossRef] [PubMed]
[28] Alli, O., Doshi, S., Kar, S., Reddy, V., Sievert, H., Mullin, C., et al. (2013) Quality of Life Assessment in the Randomized PROTECT AF (Percutaneous Closure of the Left Atrial Appendage versus Warfarin Therapy for Prevention of Stroke in Patients with Atrial Fibrillation) Trial of Patients at Risk for Stroke with Nonvalvular Atrial Fibrillation. Journal of the American College of Cardiology, 61, 1790-1798. [Google Scholar] [CrossRef] [PubMed]
[29] 曹钰, 柴艳芬, 陈康玉, 等. 急性心房颤动中国急诊管理指南(2024) [J]. 中国急救医学, 2024, 44(8): 645-667.
[30] Touboul, P. (1999) Atrioventricular Nodal Ablation and Pacemaker Implantation in Patients with Atrial Fibrillation. The American Journal of Cardiology, 83, 241-245. [Google Scholar] [CrossRef] [PubMed]
[31] Van Gelder, I.C., Rienstra, M., Crijns, H.J.G.M. and Olshansky, B. (2016) Rate Control in Atrial Fibrillation. The Lancet, 388, 818-828. [Google Scholar] [CrossRef] [PubMed]
[32] Gupta, D., Vijgen, J., Potter, T.D., Scherr, D., Van Herendael, H., Knecht, S., et al. (2021) Quality of Life and Healthcare Utilisation Improvements after Atrial Fibrillation Ablation. Heart, 107, 1296-1302. [Google Scholar] [CrossRef] [PubMed]
[33] Crowley, R., Chieng, D., Sugumar, H., Ling, L., Segan, L., William, J., et al. (2024) Catheter Ablation for Persistent Atrial Fibrillation: Patterns of Recurrence and Impact on Quality of Life and Health Care Utilization. European Heart Journal, 45, 2604-2616. [Google Scholar] [CrossRef] [PubMed]
[34] Mark, D.B., Anstrom, K.J., Sheng, S., Piccini, J.P., Baloch, K.N., Monahan, K.H., et al. (2019) Effect of Catheter Ablation vs Medical Therapy on Quality of Life among Patients with Atrial Fibrillation: The CABANA Randomized Clinical Trial. JAMA, 321, 1275-1285. [Google Scholar] [CrossRef] [PubMed]
[35] Blomström-Lundqvist, C., Gizurarson, S., Schwieler, J., Jensen, S.M., Bergfeldt, L., Kennebäck, G., et al. (2019) Effect of Catheter Ablation vs Antiarrhythmic Medication on Quality of Life in Patients with Atrial Fibrillation: The CAPTAF Randomized Clinical Trial. JAMA, 321, 1059-1068. [Google Scholar] [CrossRef] [PubMed]
[36] Monahan, K.H., Bunch, T.J., Mark, D.B., Poole, J.E., Bahnson, T.D., Al-Khalidi, H.R., et al. (2022) Influence of Atrial Fibrillation Type on Outcomes of Ablation vs. Drug Therapy: Results from Cabana. Europace, 24, 1430-1440. [Google Scholar] [CrossRef] [PubMed]
[37] Dilk, P., Wachter, R. and Hindricks, G. (2022) Catheter Ablation for Atrial Fibrillation: Impact on Mortality, Morbidity, Quality of Life, and Implications for the Future. Herz, 47, 118-122. [Google Scholar] [CrossRef] [PubMed]

为你推荐